Arexvy approval expanded to adults aged 50-59 at increased risk of severe RSV disease in Japan · First RSV vaccine approved in Japan to help protect 50-59 year olds at increased risk due to ...

GSK has become the first ... RSV in individuals 60 years of age and older, shortly after it was recommended for approval in the EU. The regulator is due to make a decision on Pfizer’s rival ...

Related First known U.S. case of mpox clade I found in Calif.; risk to public 'low' WHO approves emergency use of first mpox test Mpox vaccine protection ... 16 hours ago EU climate service ...

AstraZeneca and Sanofi have secured approval in the EU for Beyfortus, the first single-dose drug to ... especially now that Pfizer's RSV vaccine is on the brink of being submitted for approval ...

Merck's RSV antibody for infants effective in reducing ... it of misleading regulators about the effectiveness of its mumps vaccine in order to ward off competition, a federal appeals court ...

The EU in March presented its first-ever defense industrial strategy, and this year created the role of defense commissioner for the bloc. “This is the first time we use EU budget to support ...

In May 2024, the EU Council concluded that Ukraine's reform plan met the prerequisites for up to €50 billion in support, and the first tranche was transferred in August. The Ukraine Facility ...

The European Union has approved funding for joint defence procurement by its member states for the first time in its history ... Source: European Pravda, citing the European Commission Details: EU ...